Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT
- PMID: 11376257
- DOI: 10.1148/radiology.219.3.r01jn45699
Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT
Abstract
Purpose: To compare the appearance of small hepatic hemangiomas at nonenhanced and contrast material-enhanced helical computed tomography (CT) with that of small (<3-cm) hypervascular malignant liver tumors and to evaluate the accuracy of multiphase helical CT for differentiating small hemangiomas from small hypervascular malignant tumors.
Materials and methods: Radiologists reviewed multiphase helical CT liver images in 86 patients with 37 hemangiomas and 49 malignant liver tumors. They evaluated lesion type and degree of enhancement for change from arterial to portal venous phase. They rated their confidence in the discrimination of hemangiomas from malignant tumors.
Results: At arterial phase CT, enhancement similar to aortic enhancement was observed in 19%-32% of hemangiomas and 0%-2% of malignant tumors; globular enhancement, in 62%-68% and 4%-12%, respectively. At portal venous phase CT, enhancement similar to blood pool enhancement was observed in 43%-54% of hemangiomas and 4%-14% of malignant tumors; globular enhancement, in 46%-49% and 0%-2%, respectively. For all readers and all phases of enhancement, the area under the receiver operating characteristic curves was 0.81-0.87, indicating that inherent accuracy of CT is high and that there was no significant difference (P >.28) in overall accuracy. Readers diagnosed hemangiomas with 47%-53% mean sensitivity with all enhancement phases and diagnosed malignant lesions with 95% mean specificity.
Conclusion: Small hemangiomas frequently show atypical appearances at CT. Two-phase helical CT does not improve sensitivity but does improve specificity for differentiating hemangiomas from hypervascular malignant tumors.
Similar articles
-
Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT.Radiology. 2004 Aug;232(2):354-60. doi: 10.1148/radiol.2322030966. Epub 2004 Jun 23. Radiology. 2004. PMID: 15215556
-
Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases.AJR Am J Roentgenol. 1995 Dec;165(6):1403-6. doi: 10.2214/ajr.165.6.7484574. AJR Am J Roentgenol. 1995. PMID: 7484574 Clinical Trial.
-
Contrast enhancement of hepatic hemangiomas on multiphase MDCT: Can we diagnose hepatic hemangiomas by comparing enhancement with blood pool?AJR Am J Roentgenol. 2010 Aug;195(2):381-6. doi: 10.2214/AJR.09.3324. AJR Am J Roentgenol. 2010. PMID: 20651193
-
CT findings of primary clear cell carcinoma of liver: with analysis of 19 cases and review of the literature.Abdom Imaging. 2014 Aug;39(4):736-43. doi: 10.1007/s00261-014-0104-2. Abdom Imaging. 2014. PMID: 24549879 Review.
-
Comparative accuracy of intravenous contrast-enhanced CT versus noncontrast CT plus intravenous contrast-enhanced CT in the detection and characterization of patients with hypervascular liver metastases: a critically appraised topic.Acad Radiol. 2014 Jan;21(1):113-25. doi: 10.1016/j.acra.2013.08.023. Acad Radiol. 2014. PMID: 24331274 Review.
Cited by
-
MDCT of benign liver tumors and metastases.Eur Radiol. 2003 Dec;13 Suppl 5:M31-41. doi: 10.1007/s00330-003-2129-8. Eur Radiol. 2003. PMID: 14989610 Review. No abstract available.
-
Liver masses: a clinical, radiologic, and pathologic perspective.Clin Gastroenterol Hepatol. 2014 Sep;12(9):1414-29. doi: 10.1016/j.cgh.2013.09.017. Epub 2013 Sep 18. Clin Gastroenterol Hepatol. 2014. PMID: 24055987 Free PMC article. Review.
-
Technetium-99m-labelled red blood cell imaging in the diagnosis of hepatic haemangiomas: the role of SPECT/CT with a hybrid camera.Eur J Nucl Med Mol Imaging. 2004 Jul;31(7):1011-5. doi: 10.1007/s00259-004-1518-9. Epub 2004 Mar 31. Eur J Nucl Med Mol Imaging. 2004. PMID: 15057491 Clinical Trial.
-
Differentiating Liver Hemangioma from Metastatic Tumor Using T2-enhanced Spin-echo Imaging with a Time-reversed Gradient-echo Sequence in the Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging.Magn Reson Med Sci. 2022 Jul 1;21(3):445-457. doi: 10.2463/mrms.mp.2020-0151. Epub 2021 Apr 20. Magn Reson Med Sci. 2022. PMID: 33883364 Free PMC article.
-
Differentiation of Hepatocellular Carcinoma from Hepatic Hemangioma and Focal Nodular Hyperplasia using Computed Tomographic Spectral Imaging.J Clin Transl Hepatol. 2021 Jun 28;9(3):315-323. doi: 10.14218/JCTH.2020.00173. Epub 2021 Mar 31. J Clin Transl Hepatol. 2021. PMID: 34221917 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical